Active, not recruitingNot applicableNCT04243005

Supramarginal Resection in Glioblastoma

Studying Giant cell glioblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
St. Olavs Hospital
Principal Investigator
Asgeir S Jakola, MD, PhD
St.Olavs University Hospital and Sahlgrenska University Hospital
Intervention
Supramarginal resection(procedure)
Enrollment
90 enrolled
Eligibility
18 years · All sexes
Timeline
2020 – 2030

Study locations (17)

Collaborators

Odense University Hospital · Sahlgrenska University Hospital · Turku University Hospital · Karolinska University Hospital · Norwegian University of Science and Technology · Uppsala University Hospital · University Hospital, Umeå · Haukeland University Hospital · Ullevaal University Hospital · Rikshospitalet University Hospital · Tampere University Hospital · Helsinki University Central Hospital · Kuopio University Hospital · Oulu University Hospital · Medical University of Vienna · Paracelsus Medical University · Medical Center Haaglanden, The Hague, The Netherlands · Erasmus Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04243005 on ClinicalTrials.gov

Other trials for Giant cell glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Giant cell glioblastoma →

← Back to all trials